Merus N.V. CS (MRUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRUS | KYMR | PTGX | ||
| Company | Merus N.V. CS | Kymera Therapeutics Inc | Protagonist Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 96.86 | 87.75 | 105.57 | ||
| High | 96.86 | 88.45 | 106.90 | ||
| Low | 87.14 | 87.06 | 103.51 | ||
| Latest | 90.00 | 87.71 | 105.98 | ||
| Change | -6.92 | +1.57 | +2.25 | ||
| % Change | -7.14% | +1.82% | +2.17% | ||
| Volume | 2,728,600 | 587,300 | 1,006,300 | ||
| 20-Day Average Volume | 1,160,195 | 646,155 | 854,705 | ||
| Previous Close | 96.92 | 86.14 | 103.73 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 96.27 | 83.54 | 102.25 | ||
| 20-Day Raw Stochastic | 28.60% | 85.54% | 85.05% | ||
| 20-Day Relative Strength | 26.76 | 56.35 | 59.45 | ||
| Weighted Alpha | +65.99 | +80.57 | +112.40 | ||
| Today's Opinion | 64% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 64% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.23% since 12/19/25 | +3.13% since 04/10/26 | +7.25% since 04/10/26 | ||
| Low | 87.14 on 12/29/25 | 84.64 on 04/16/26 | 95.40 on 04/13/26 | ||
| High | 97.02 on 12/22/25 | 90.14 on 04/15/26 | 106.90 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | -6.39% since 11/28/25 | +8.00% since 03/17/26 | +9.00% since 03/17/26 | ||
| Low | 87.14 on 12/29/25 | 73.31 on 03/24/26 | 90.58 on 03/18/26 | ||
| High | 97.14 on 12/19/25 | 90.14 on 04/15/26 | 107.84 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | -3.92% since 09/29/25 | +26.13% since 01/16/26 | +29.26% since 01/16/26 | ||
| Low | 87.14 on 12/29/25 | 66.21 on 01/20/26 | 77.00 on 02/23/26 | ||
| High | 97.14 on 12/19/25 | 95.90 on 02/26/26 | 107.84 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | +69.84% since 06/27/25 | +46.60% since 10/17/25 | +36.75% since 10/17/25 | ||
| Low | 51.78 on 07/08/25 | 55.26 on 10/23/25 | 73.08 on 10/23/25 | ||
| High | 97.14 on 12/19/25 | 103.00 on 12/08/25 | 107.84 on 04/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,826,230 | 7,160,819 | 6,762,477 | ||
| Shares Outstanding, K | 75,847 | 81,642 | 63,809 | ||
| Annual Sales | 36,130,000 | 39,210,000 | 46,020,000 | ||
| Annual Net Income | -215,330,000 | -311,350,000 | -130,150,000 | ||
| Last Quarter Sales | 12,150,000 | 2,870,000 | 7,440,000 | ||
| Last Quarter Net Income | -95,520,000 | -86,980,000 | -44,380,000 | ||
| 60-Month Beta | 1.06 | 2.28 | 2.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.23 on 10/31/25 | -0.97 on 02/26/26 | -0.69 on 02/25/26 | ||
| Latest Earnings Date | 02/26/26 | 05/08/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||